Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients

NCT01128335 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

200

Enrollment

INDUSTRY

Sponsor class

Conditions

Liver Transplantation

Interventions

DRUG: MMF(1000mg bid) + tacrolimus + standard of care medications
DRUG: sotrastaurin (200mg bid) + tacrolimus + standard of care medications
DRUG: sotrastaurin (200mg bid) + tacrolimus + standard of care medications
DRUG: sotrastaurin (300 mg bid) + tacrolimus + standard of care medications

Sponsor

Novartis Pharmaceuticals